Search research articles
Contact Us
Filters
Showing results (31-40 of 166) with videos related to
Page
of 17
Sort By:
British Journal of Clinical Pharmacology
|
June 1, 1997
Association between CYP2C19 genotype and proguanil oxidative polymorphism
J K Coller, A A Somogyi, F Bochner
Clinical Pharmacokinetics
|
November 1, 1991
Bioinequivalence of four 100 mg oral aspirin formulations in healthy volunteers
F Bochner, A A Somogyi, K M Wilson
Journal of Chromatography. B, Biomedical Sciences and Applications
|
September 14, 2000
Stereoselective quantification of methadone and its major oxidative metabolite, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, in human urine using high-performance liquid chromatography
D J Foster, A A Somogyi, F Bochner
The Medical Journal of Australia
|
February 3, 1997
The agony of "ecstasy"
J M White, F Bochner, R J Irvine
The Medical Journal of Australia
|
September 6, 1980
Comparative bioavailability study of theophylline tablets marketed in Australasia
B G Charles, P J Ravenscroft, F Bochner
The Medical Journal of Australia
|
April 4, 1981
Hallucinogenic drug induced vasculitis
V J Heazlewood, F Bochner, P W Craswell
British Journal of Clinical Pharmacology
|
May 8, 1999
Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4
D J Foster, A A Somogyi, F Bochner
British Journal of Clinical Pharmacology
|
March 1, 1996
Pharmacokinetic evaluation of proguanil: a probe phenotyping drug for the mephenytoin hydroxylase polymorphism
A A Somogyi, H A Reinhard, F Bochner
British Journal of Clinical Pharmacology
|
January 1, 1990
Amiloride disposition in geriatric patients: importance of renal function
A Somogyi, D Hewson, M Muirhead, et al.
The Medical Journal of Australia
|
May 5, 1979
Severe hyperkalaemia with Moduretic
G F Whiting, C J McLaran, F Bochner
Page
of 17
Search research articles
Search
Showing results (31-40 of 166) with videos related to
Sort By:
Page
of 17
British Journal of Clinical Pharmacology
|
June 1, 1997
Association between CYP2C19 genotype and proguanil oxidative polymorphism
J K Coller, A A Somogyi, F Bochner
Clinical Pharmacokinetics
|
November 1, 1991
Bioinequivalence of four 100 mg oral aspirin formulations in healthy volunteers
F Bochner, A A Somogyi, K M Wilson
Journal of Chromatography. B, Biomedical Sciences and Applications
|
September 14, 2000
Stereoselective quantification of methadone and its major oxidative metabolite, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, in human urine using high-performance liquid chromatography
D J Foster, A A Somogyi, F Bochner
The Medical Journal of Australia
|
February 3, 1997
The agony of "ecstasy"
J M White, F Bochner, R J Irvine
The Medical Journal of Australia
|
September 6, 1980
Comparative bioavailability study of theophylline tablets marketed in Australasia
B G Charles, P J Ravenscroft, F Bochner
The Medical Journal of Australia
|
April 4, 1981
Hallucinogenic drug induced vasculitis
V J Heazlewood, F Bochner, P W Craswell
British Journal of Clinical Pharmacology
|
May 8, 1999
Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4
D J Foster, A A Somogyi, F Bochner
British Journal of Clinical Pharmacology
|
March 1, 1996
Pharmacokinetic evaluation of proguanil: a probe phenotyping drug for the mephenytoin hydroxylase polymorphism
A A Somogyi, H A Reinhard, F Bochner
British Journal of Clinical Pharmacology
|
January 1, 1990
Amiloride disposition in geriatric patients: importance of renal function
A Somogyi, D Hewson, M Muirhead, et al.
The Medical Journal of Australia
|
May 5, 1979
Severe hyperkalaemia with Moduretic
G F Whiting, C J McLaran, F Bochner
Page
of 17